Evaluation of a novel nicotine inhaler device: Part 1-arterial and venous pharmacokinetics

Nicotine and Tobacco Research

Volumn 17, Issue 1, 2015, Pages 18-25

  Moyses, Chris ^a   Hearn, Alex ^a   Redfern, Andrew ^b  

^a Kind Consumer Limited   (United Kingdom)

^b Linear Clinical Research   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICOTINE GUM; NICOTINE;

ADULT; AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTICLE; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DIZZINESS; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRY THROAT; FEMALE; HUMAN; INHALER; LIMIT OF QUANTITATION; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; ORAL PARESTHESIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; SMOKING; THROAT IRRITATION; TIME TO MAXIMUM PLASMA CONCENTRATION; VENOUS BLOOD; WAKEFULNESS; ADOLESCENT; BLOOD; CLINICAL TRIAL; DRUG THERAPY; GREAT BRITAIN; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; MIDDLE AGED; NEBULIZER; PROCEDURES; SMOKING CESSATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; FEMALE; GREAT BRITAIN; HUMANS; LUNG; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; NICOTINE; SMOKING; SMOKING CESSATION;

EID: 84922469343     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu228     Document Type: Article

References (25)

1. Health and Social Care Information Centre. Statistics on Smoking, England 2013. https://catalogue.ic.nhs.uk/publications/public-health/smoking/smok-eng-2013/smok-eng-2013-rep.pdf. Accessed November 10, 2014.
2. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2008: The MPOWER Package.
3. National Institute for Health and Care Excellence. Smoking Cessation Services, 2008:88. http://guidance.nice.org.uk/PH10. Accessed November 10, 2014.
4. West R, May S, West M, Croghan E, McEwen A. Performance of English stop smoking services in first 10 years: analysis of service monitoring data. Br Med J. 2013;347:f4921.
5. West R, Owen L. Estimates of 52-Week Continuous Abstinence Rates Following Selected Smoking Cessation Interventions in England, 2012: 1-6. http://www.smokinginengland.info/sts-documents/. Accessed November 10, 2014.
6. Henningfield J, Stapleton J, Benowitz N, Grayson R, London E. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 1993;33:23-29.
7. Schneider NG, Olmstead RE, Franzon MA, Lunell E. The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet. 2001;40:661-684.
8. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res. 2012;14:75-78.
9. Rose JE. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology (Berl). 2006;184:274-285.
10. National Institute for Health and Care Excellence. NICE Public Health Guidance 45. Tobacco: Harm-Reduction Approaches to Smoking, 2013:94. http://guidance.nice.org.uk/PH45. Accessed November 10, 2014.
11. MHRA. MHRA Public Assessment Report. The Use of Nicotine Replacement Therapy to Reduce Harm in Smokers, 2010:1-9. http://www.mhra.gov.uk/home/groups/es-policy/documents/publication/con068571.pdf. Accessed November 10, 2014.
12. Royal College of Physicians. Ending Tobacco Smoking in Britain: Radical Strategies for Prevention and Harm Reduction in Nicotine Addiction. A Report by the Tobacco Advisory Group of the Royal College of Physicians, London, UK: Royal College of Physicians; 2008. https://www.rcplondon.ac.uk/sites/default/files/documents/ending-tobacco-smoking.pdf. Accessed November 10, 2014.
13. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133-139.
14. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised crossover trial. Tob Control. 2010;19:98-103.
15. Chunn Lindsay J. Technical Review and Analysis of FDA Report: "Evaluation of E-Cigarettes". Houston, TX Exponent, Inc.; 2009:13. http://www.stop-tabac.ch/fra/images/stories/documents_stop_tabac/exponent%20response-to-the-fda-summary.pdf. Accessed November 10, 2014.
16. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19:1945-1953.
17. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15: 267-270.
18. Williams M, Talbot P. Variability among electronic cigarettes in the pressure drop, airflow rate, and aerosol production. Nicotine Tob Res. 2011;13:1276-1283.
19. Moyses C, Hearn A, Redfern A. Evaluation of a novel nicotine inhaler device. Part 2: effect on craving and smoking urges. Nicotine Tob Res. July 31, 2014 [Epub ahead of print]. doi:10.1093/ntr/ntu122.
20. McNeil Products Limited. Nicorette Nasal Spray SPC, 2012. http://www.medicines.org.uk/emc/medicine/20679. Accessed November 10, 2014.
21. Gourlay SG, Benowitz NL. Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine. Clin Pharmacol Ther. 1997;62:453-463.
22. Caldwell B, Dickson S, Burgess C, et al. A pilot study of nicotine delivery to smokers from a metered-dose inhaler. Nicotine Tob Res. 2009;11:342-347.
23. Russell MA, Feyerabend C, Cole PV. Plasma nicotine levels after cigarette smoking and chewing nicotine gum. Br Med J. 1976;1:1043-1046.
24. Lunell E, Molander L, Ekberg K, Wahren J. Site of nicotine absorption from a vapour inhaler-comparison with cigarette smoking. Eur J Clin Pharmacol. 2000;55:737-741.
25. Bridgman K, Norton R, Mullin M. Safety and tolerability of a novel nicotine inhaler device: results from a simulated test market study. Presented at 19th Annual International Meeting of the Society for Research on Nicotine and Tobacco; March 13-16, 2013; Boston, MA. Poster 180.